Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

By Temple Lung Center FEATURING Daniel Salerno

178 views

March 7, 2022

Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients ...
read more ↘ causing pulmonary dysfunction. Daniel Salerno, MD, is the principle investigator for a study designed to determine if clofazimine has anit-mycobacteral activity against MAC. In this video Dr. Salerno explains the study objectives, design as well as patient eligibility criteria, and how to enroll patients who may be candidates.
↖ read less

Comments 0